FOXO3 and breast carcinoma: These results offer new insight into the crosstalk between breast cancer cells and bone cells of the tumour microenvironment, and provide evidence to show that disruption of IKKβ and its interaction with FoxO3a may have potential therapeutic efficacy in all stages of breast cancer.